Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00394563 · ClinicalTrials.gov registry record · Phase 2
A Phase II Study Looking at Moderate to Severe Osteoarthritis Knee Pain
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 450
- Enrollment target
NCT00394563: Completed Phase 2 study, sponsored by Pfizer.
NCT00394563 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 450 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (238% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00394563, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 450 participants
- Enrollment target
Study Summary
The purpose of this study is to look at the effects of RN624 on moderate to severe knee pain due to osteoarthritis. This study will look at the safety and pain relieving effects of RN624 compared to placebo over a 4 month period.
Interventions
- DRUG RN624 (PF-04383119)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2006-03 |
| Est. Completion | 2007-10 |
| Phase | Phase 2 |
What the finished NCT00394563 record still lists
NCT00394563 is an interventional study that assigns participants to a tested intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (238% higher).
The record links to 0 conditions, and to 1 intervention - of which RN624 (PF-04383119) is the first listed.
NCT00394563 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00394563 about?
NCT00394563 is a clinical study titled "A Phase II Study Looking at Moderate to Severe Osteoarthritis Knee Pain". The purpose of this study is to look at the effects of RN624 on moderate to severe knee pain due to osteoarthritis. This study will look at the safety and pain relieving effects of RN624 compared to placebo over a 4 month period.
What is the current status of trial NCT00394563?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 450 participants. The study started on 2006-03. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00394563?
The interventions under investigation include: RN624 (PF-04383119) (DRUG).
Who is sponsoring clinical trial NCT00394563?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00394563's enrollment target sits among peer trials
450 87th of 2000 higher than 1,912 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia